Impact of personalized diabetes care on distress and treatment satisfaction in people with breast cancer

Julia C. Harrod,Yee‐Ming M. Cheung,Lauren Buckley,Grace E. Cromwell,Kristen M. Fowler,Melissa E. Hughes,Nancy U. Lin,Sara M. Tolaney,Le Min,Marie E. McDonnell
DOI: https://doi.org/10.1111/dme.15292
IF: 3.5
2024-02-01
Diabetic Medicine
Abstract:Aims In patients with breast cancer (BCa) and diabetes (DM), diabetes distress (DD) and treatment satisfaction (DTS) can influence BCa management and outcomes. We assessed the impact of implementing a personalized diabetes care model in patients with BCa. Methods Patients in active treatment or surveillance for BCa with an HbA1c > 53 mmol/mol (7%) or random blood glucose >11.1 mmol/L were included. Participants were offered continuous glucose monitoring (CGM), virtual care and a dedicated diabetes provider for 6 months. Primary outcomes included DD measured by the Diabetes Distress Survey (DDS) and DTS measured by the Diabetes Treatment Satisfaction Questionnaire (DTSQ). Questionnaires were conducted at 0, 3 and 6 months. Results Thirty‐one women were enrolled (median age 61, IQR 49.0–69.0). Compared to baseline, the mean DDS score was lower at both 3 months (2.2 vs. 1.8 [n = 27], p = 0.004, SD = 0.70) and 6 months (2.3 vs. 1.8 [n = 23], p = 0.002, SD = 0.70). The mean DTSQ score was higher at 3 months (baseline: 20.5 vs. 3 months: 28.7 [n = 28], p
endocrinology & metabolism
What problem does this paper attempt to address?